Dermatology

• In the Journals

• Lambrolizumab shows promise in melanoma

• June 17, 2013
• The novel anti–PD-1 antibody lambrolizumab was associated with response rates of more than 35% in a cohort of patients with advanced melanoma,...More »

• Video

• T-VEC yielded encouraging response rates and survival outcomes in unresected melanoma

• June 17, 2013
• CHICAGO — Robert Andtbacka, MD, CM, a surgical oncologist at the Huntsman Cancer Institute in Salt Lake City, Utah, discussed encouraging results...More »

• In the Journals

• Combined factors helped predict positive SLN risk in patients with T1 melanoma

• June 14, 2013
• Clinical and histologic prognostic factors in combination might help identify subgroups of patients with T1 melanoma at higher risk for sentinel lymph...More »

• In the Journals

• 48% of dermatology chief residents reported specialized dermoscopy training

• June 12, 2013
• While most dermatology chief residents surveyed used dermoscopy, less than half reported training with a pigmented lesion specialist, according to recent...More »

• Meeting News Coverage Perspective

• Selumetinib increased PFS, reduced tumor size in uveal melanoma

• June 6, 2013
• CHICAGO — Selumetinib decreased tumor size in 50% of patients with metastatic uveal melanoma and was associated with a twofold increased PFS when...More »

• In the Journals

• Most skin cancer patients did not use sunscreen while driving

• June 4, 2013
• Almost 75% of patients seen at a Mohs micrographic surgery center reported not using sunscreen while in an automobile, according to study results.
  ...More »

• Meeting News Coverage Perspective

• GM-CSF plus ipilimumab extended OS in metastatic melanoma

• June 1, 2013
• CHICAGO — The addition of granulocyte-macrophage colony-stimulating factor to an increased dose of ipilimumab extended OS among patients with...More »

• Physicians Avoid Tanning Beds

• June 1, 2013
• Richard W. Joseph, MD, medical oncologist, and Anokhi Jambusaria, MD, dermatologist, both from Mayo Clinic in Florida talk about why one should NEVER use ......More »

• Meeting News Coverage Perspective

• PD-L1 targeted antibody induced tumor shrinkage in several cancer types

• May 31, 2013
• The investigational drug MPDL3280A, an engineered PD-L1 targeted antibody, significantly improved tumor shrinkage rates in patients with locally advanced...More »

• In the Journals

• Reality TV beauty show viewership related to indoor, outdoor tanning

• May 31, 2013
• Watching reality TV beauty shows was associated with tanning lamp use and outdoor tanning among college students, according to study results.
  Researchers...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!